USP <797> Overview
In this video, Matt Martin, PharmD, provides a comprehensive overview of proposed changes to USP Chapter <797> prior to publication of the chapter on June 1, 2019.
Notable Changes in the New USP <797>
Dylan Herr, RA/QA Development Manager at Eagle, understands that the revised USP <797> chapter for sterile compounding makes significant revisions to the old chapter. In this latest article, Dyan is happy to provide you with an overview of those changes and strategies for implementing them.
Read Article
ScanRDI® Sterility Test Protocol
A faster way to comply with USP <797
> and ensure your patients are receiving quality compounds, the ScanRDI can deliver results in as little as one business day, and it fulfills the method suitability requirement as outlined in USP <1223>.
Learn More
USP
USP General Chapter <797> Pharmaceutical Compounding – Sterile Preparations
View